Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

Workshop report: Nucleic acid delivery devices for HIV vaccines: Workshop proceedings, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, USA, May 21, 2015.

Weniger BG, Anglin IE, Tong T, Pensiero M, Pullen JK; Nucleic Acid Delivery Devices for HIV Vaccines Workshop Group.

Vaccine. 2018 Jan 25;36(4):427-437. doi: 10.1016/j.vaccine.2017.10.071. Epub 2017 Nov 22.

PMID:
29174315
2.

Now that you want to take your HIV/AIDS vaccine/biological product research concept into the clinic: what are the "cGMP"?

Sheets RL, Rangavajhula V, Pullen JK, Butler C, Mehra V, Shapiro S, Pensiero M.

Vaccine. 2015 Apr 8;33(15):1757-66. doi: 10.1016/j.vaccine.2015.02.003. Epub 2015 Feb 16. Review.

3.

Design and testing for a nontagged F1-V fusion protein as vaccine antigen against bubonic and pneumonic plague.

Powell BS, Andrews GP, Enama JT, Jendrek S, Bolt C, Worsham P, Pullen JK, Ribot W, Hines H, Smith L, Heath DG, Adamovicz JJ.

Biotechnol Prog. 2005 Sep-Oct;21(5):1490-510.

PMID:
16209555
4.

Antitumor efficacy of Venezuelan equine encephalitis virus replicon particles encoding mutated HPV16 E6 and E7 genes.

Cassetti MC, McElhiney SP, Shahabi V, Pullen JK, Le Poole IC, Eiben GL, Smith LR, Kast WM.

Vaccine. 2004 Jan 2;22(3-4):520-7.

PMID:
14670335
5.

Establishment of an HLA-A*0201 human papillomavirus type 16 tumor model to determine the efficacy of vaccination strategies in HLA-A*0201 transgenic mice.

Eiben GL, Velders MP, Schreiber H, Cassetti MC, Pullen JK, Smith LR, Kast WM.

Cancer Res. 2002 Oct 15;62(20):5792-9.

6.

Protective efficacy of recombinant Yersinia outer proteins against bubonic plague caused by encapsulated and nonencapsulated Yersinia pestis.

Andrews GP, Strachan ST, Benner GE, Sample AK, Anderson GW Jr, Adamovicz JJ, Welkos SL, Pullen JK, Friedlander AM.

Infect Immun. 1999 Mar;67(3):1533-7.

7.

Analysis of the Yersinia pestis V protein for the presence of linear antibody epitopes.

Pullen JK, Anderson GW Jr, Welkos SL, Friedlander AM.

Infect Immun. 1998 Feb;66(2):521-7.

8.
9.

Production of Haemophilus influenzae type-b porin in Escherichia coli and its folding into the trimeric form.

Pullen JK, Liang SM, Blake MS, Mates S, Tai JY.

Gene. 1995 Jan 11;152(1):85-8.

PMID:
7828934
10.

Recognition of a single amino acid change on the surface of a major transplantation antigen is in the context of self peptide.

Pullen JK, Tallquist MD, Melvold RW, Pease LR.

J Immunol. 1994 Apr 1;152(7):3445-52.

PMID:
8144927
11.

Structural analysis of H-2Kj and H-2Ku.

Pogulis RJ, Pullen JK, Rohren EM, Pease LR.

Immunogenetics. 1994;39(5):371. No abstract available.

PMID:
8168857
12.

Unusual mutation clusters provide insight into class I gene conversion mechanisms.

Pease LR, Horton RM, Pullen JK, Yun TJ.

Mol Cell Biol. 1993 Jul;13(7):4374-81.

13.

Amino acid changes in the peptide binding site have structural consequences at the surface of class I glycoproteins.

Pease LR, Horton RM, Pullen JK, Hunt HD, Yun TJ, Rohren EM, Prescott JL, Jobe SM, Allen KS.

J Immunol. 1993 Apr 15;150(8 Pt 1):3375-81.

PMID:
7682238
14.

Gene splicing by overlap extension.

Horton RM, Ho SN, Pullen JK, Hunt HD, Cai Z, Pease LR.

Methods Enzymol. 1993;217:270-9. No abstract available.

PMID:
8474334
15.

Structural diversity of the classical H-2 genes: K, D, and L.

Pullen JK, Horton RM, Cai ZL, Pease LR.

J Immunol. 1992 Feb 1;148(3):953-67.

PMID:
1730883
16.

Specific amplification of complementary DNA from targeted members of multigene families.

Cai Z, Pullen JK, Horton RM, Pease LR.

Methods Enzymol. 1992;216:100-8. No abstract available.

PMID:
1282643
17.

Peptide interactions with the Kb antigen recognition site.

Pullen JK, Hunt HD, Pease LR.

J Immunol. 1991 Apr 1;146(7):2145-51.

PMID:
2005392
18.

Structure and diversity of class I antigen presenting molecules in the mouse.

Pease LR, Horton RM, Pullen JK, Cai ZL.

Crit Rev Immunol. 1991;11(1):1-32. Review.

PMID:
1883507
19.

Structural basis of Kbm8 alloreactivity. Amino acid substitutions on the beta-pleated floor of the antigen recognition site.

Hunt HD, Pullen JK, Dick RF, Bluestone JA, Pease LR.

J Immunol. 1990 Sep 1;145(5):1456-62.

PMID:
2384667
20.

Positive selection of transgenic receptor-bearing thymocytes by Kb antigen is altered by Kb mutations that involve peptide binding.

Sha WC, Nelson CA, Newberry RD, Pullen JK, Pease LR, Russell JH, Loh DY.

Proc Natl Acad Sci U S A. 1990 Aug;87(16):6186-90.

21.
22.

Regulation of MHC gene expression during the differentiation of bone marrow-derived macrophages.

Pullen JK, Eustis-Turf E, Myers MJ, Schook LB.

Cell Immunol. 1989 Jul;121(2):398-413.

PMID:
2500255
23.

Engineering hybrid genes without the use of restriction enzymes: gene splicing by overlap extension.

Horton RM, Hunt HD, Ho SN, Pullen JK, Pease LR.

Gene. 1989 Apr 15;77(1):61-8.

PMID:
2744488
24.

Site-directed mutagenesis by overlap extension using the polymerase chain reaction.

Ho SN, Hunt HD, Horton RM, Pullen JK, Pease LR.

Gene. 1989 Apr 15;77(1):51-9.

PMID:
2744487
25.

Regulation of IL-1 and TNF-alpha expression during the differentiation of bone marrow derived macrophage.

Myers MJ, Pullen JK, Ghildyal N, Eustis-Turf E, Schook LB.

J Immunol. 1989 Jan 1;142(1):153-60.

PMID:
2642503
26.
27.

Supplemental Content

Loading ...
Support Center